Follow
Arun Iyer, PhD, Associate Professor of Pharmaceutical Sciences
Arun Iyer, PhD, Associate Professor of Pharmaceutical Sciences
Wayne State University, Karmanos Cancer Institute, UCSF, Northeastern University
Verified email at wayne.edu - Homepage
Title
Cited by
Cited by
Year
Exploiting the enhanced permeability and retention effect for tumor targeting
AK Iyer, G Khaled, J Fang, H Maeda
Drug discovery today 11 (17-18), 812-818, 2006
22182006
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers in pharmacology 8, 561, 2017
16372017
siRNA delivery strategies: a comprehensive review of recent developments
K Tatiparti, S Sau, SK Kashaw, AK Iyer
Nanomaterials 7 (4), 77, 2017
4632017
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
P Kesharwani, AK Iyer
Drug discovery today 20 (5), 536-547, 2015
3662015
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
S Ganesh, AK Iyer, DV Morrissey, MM Amiji
Biomaterials 34 (13), 3489–3502, 2013
3652013
Role of Integrated Cancer Nanomedicine in Overcoming Drug Resistance
A Iyer, A Singh, M Ganta, Srinivas, Amiji
Advanced Drug Delivery Reviews, 2013
3552013
PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery
D Luong, P Kesharwani, R Deshmukh, MCIM Amin, U Gupta, K Greish, ...
Acta biomaterialia 43, 14-29, 2016
3392016
Tumor-targeted induction of oxystress for cancer therapy
J Fang, H Nakamura, AK Iyer
Journal of drug targeting 15 (7-8), 475-486, 2007
2872007
PAMAM dendrimers as promising nanocarriers for RNAi therapeutics
P Kesharwani, S Banerjee, U Gupta, MCIM Amin, S Padhye, FH Sarkar, ...
Materials Today 18 (10), 565-572, 2015
2692015
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
AK Sharma, A Gothwal, P Kesharwani, H Alsaab, AK Iyer, U Gupta
Drug Discovery Today 22 (2), 314-326, 2017
2252017
Doxorubicin loaded polymeric nanoparticulate delivery system to overcome drug resistance in osteosarcoma
M Susa, AK Iyer, K Ryu, FJ Hornicek, H Mankin, MM Amiji, Z Duan
BMC cancer 9, 1-12, 2009
2052009
Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3, 4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells
P Kesharwani, L Xie, S Banerjee, G Mao, S Padhye, FH Sarkar, AK Iyer
Colloids and Surfaces B: Biointerfaces 136, 413-423, 2015
2022015
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
JM Wickens, HO Alsaab, P Kesharwani, K Bhise, MCIM Amin, RK Tekade, ...
Drug discovery today 22 (4), 665-680, 2017
1782017
Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
M Susa, A Iyer, K Ryu, E Choy, F Hornicek, H Mankin, L Milane, M Amiji, ...
PLOS One, 2010
1752010
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma
M Susa, AK Iyer, X Liu, E Choy, FJ Hornicek, H Mankin, L Milane, ...
Cancer Research 70 (8 Supplement), 3526-3526, 2010
1752010
Advances in antibody–drug conjugates: A new era of targeted cancer therapy
S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer
Drug Discovery Today 22 (10), 1547-1556, 2017
1642017
Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy
MW Amjad, P Kesharwani, MCIM Amin, AK Iyer
Progress in polymer science 64, 154-181, 2017
1582017
In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
S Ganesh, AK Iyer, F Gattacceca, DV Morrissey, MM Amiji
Journal of Controlled Release, 2013
1522013
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
S Sau, HO Alsaab, K Bhise, R Alzhrani, G Nabil, AK Iyer
Journal of controlled release 274, 24-34, 2018
1502018
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
X Yang, AK Iyer, A Singh, E Choy, FJ Hornicek, MM Amiji, Z Duan
Scientific Reports 5 (8509), 2015
1472015
The system can't perform the operation now. Try again later.
Articles 1–20